首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1063199

病毒過濾的全球市場(2022年～2029年)

Global Virus Filtration Market - 2022-2029

出版日期: 2022年03月03日 | 出版商:

DataM Intelligence | 英文 190 Pages | 商品交期: 約2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

本報告提供全球病毒過濾市場相關調查分析，提供市場動態，產業分析，市場分析，競爭情形等系統性資訊。

簡介
- 市場規模分析，及與前一年同期比較成長分析(%):各終端用戶
- 市場魅力指數:各終端用戶
製藥及生物科技企業*
- 簡介
- 市場規模分析，100萬美元(2020年～2029年)，及與前一年同期比較成長分析(%)(2021年～2029年)
受託研究機構(CRO)
其他

第10章全球病毒過濾市場:各地區

簡介
- 市場規模分析，100萬美元(2020年～2029年)，及與前一年同期比較成長分析(%)(2021年～2029年):各地區
- 市場魅力指數:各地區
北美
歐洲
南美
亞太地區
中東和非洲

第11章全球病毒過濾市場-競爭情形

主要的開發與策略
企業佔有率分析
產品的基準

第12章全球病毒過濾市場-企業簡介概要

Asahi Kasei Medical Co. Ltd*
- 企業概要
- 產品系列及說明
- 主要亮點
- 財務概要
Charles River Laboratories International Inc.
General Electric Company
Pall Corporation
Merck KgaA
Sartorius Group
Pendotech

第13章全球病毒過濾市場-DataM

附錄
關於本公司·服務
諮詢方式

簡介目錄

Product Code: DMLE4823

Market Overview

The global virus filtration market size was valued at US$ XX million in 2021 and is estimated to reach US$ XX million by 2029, growing at a CAGR of XX % during the forecast period (2022-2029).

To retain virus particles, virus filtration employs a membrane barrier. A size-based virus removal method employs a specially designed polymeric membrane to retain virus particles on the membrane's surface and within its pores.

Market Dynamics

The factors influencing the global virus filtration market are the increasing R&D and the increasing prevalence of chronic diseases.

The increasing R&D is expected to drive the global virus filtration market in the forecast period

Virus filtration is an effective and robust dedicated viral clearance step used in biopharmaceutical manufacturing. Virus filtration is critical in producing biotherapeutic products because it effectively removes potential viral contaminants. Biological materials are used to produce many biopharmaceutical therapies, such as mAbs and blood plasma factors. This increases the possibility that microorganisms, such as viral contaminants, will unintentionally be introduced into the manufacturing process and contaminate the product. As a result, it is critical to remove such harmful agents using effective viral filtration methods. It is critical that downstream purification processes effectively remove actual and potential viral contaminants during biotherapeutics manufacturing from mammalian cell culture or plasma. Because virus removal by filtration is primarily a size-based mechanism, effective clearance can be achieved for various virus types, regardless of their physicochemical properties. Virus filtration is also one of the few unit operations capable of removing small nonenveloped viruses that are resistant to inactivation and may be difficult to remove via chromatography steps. Virus filtration does not affect product quality, making it an ideal solution for improving the safety of most biological products. Virus filtration is one of the most effective and robust methods of enhancing the safety of biological products. Hence, the increasing use of virus filtration in biopharmaceutical R&D processes is expected to drive market growth in the forecast period.

The problems associated with virus filtration is expected to hamper the market growth

There are various problems associated with virus filtration, which are expected to hamper market growth. For instance, because of the non-representative volumetric throughputs (L/m2) that can be seen with the addition of the virus spike, the traditional approach to virus filter spiking studies (virus added to the feed solution before the start of filtration) can result in large viral filtration systems. The reduction in throughput results from interactions between the species in the virus stock solution alone or combined with the species in the drug product. The conventional approach assumes that virus filter log reduction value (LRV) is directly related to volumetric throughput and limits manufacturing scale designs to the volumetric throughput obtained in the spiking study. Implementing a virus-retentive filter is just one of the many steps a manufacturer will take to ensure product safety. The selection of a virus filter is primarily influenced by robust virus retention. Nonetheless, strong retention should be achieved as cheaply as possible. This brief overview of regulatory, process and filter-related considerations should help filter users choose the right virus filter and begin filter optimization studies. Hence, choosing a virus filter is an important step and can impact the process.

COVID-19 Impact Analysis

Central furnace filters, also known as HVAC filters, filter the air throughout a home. Portable air cleaners and HVAC filters can help to reduce airborne pollutants in the home, including viruses. Portable air cleaners and HVAC filters are insufficient to protect people from the virus that causes COVID-19. Portable air filters effectively remove SARS-CoV-2 particles from the air, according to research at a hospital swamped by people with COVID-19, the first such evidence in a real-world setting. According to the study, the findings suggest that air filters could be used in hospitals to reduce the risk of patients and medical staff contracting SARS-CoV-2. Despite personal protective equipment, hospitals have reported significant SARS-CoV-2 transmission from patients to healthcare workers. Viral particles in the air, which are one of the main drivers of SARS-CoV-2 transmission, are one suspected cause of such cases. Hence, the global virus filtration market is expected to grow during COVID-19, increasing the demand for portable air cleaners and HVAC filters.

Segment Analysis

The kits, reagents, and consumables segment is expected to dominate the market growth

The kits, reagents, and consumables category are significant in the virus filtration market. The reagents help to reduce the risk of pathogenic virus transmission during surgery. The reagents aid in identifying viruses that are likely to contaminate the cell substrate or any other reagents or materials used during the evaluation process.

Qiagen and Merck Millipore are two well-known manufacturers of virus filtration reagents and kits. Blood, plasma, serum, or bodily fluids, as well as monoclonal antibodies and recombinant proteins, may be used to produce biopharmaceuticals. Several biologic and pharmaceutical companies are also increasing their investments in the research and development of vaccines, protein therapeutics, blood products, cellular therapy products, gene therapy products, tissue products, etc.

Geographical Analysis

North America region is expected to hold the largest market share in the global virus filtration market

Due to an increase in disease incidence and more pharmaceutical companies in the region. The United States has the largest market share in North America. Furthermore, there has been increased regulatory scrutiny involving adventitious viruses in manufacturing processes in recent years. Biologics demand is expected to drive the viral filtration market during the forecast period, owing to increased R&D by biopharmaceutical companies. The presence of major companies in this region is also expected to drive market growth. For instance, Pall Corporation manufactures high-tech filtration, separation, and purification, serving customers' diverse needs in various applications. The company is headquartered in Port Washington, United States. The company manufactures Pegasus Prime Virus Removal Filter Membrane in Pall Kleenpa Nova Capsules and Cartridges. The first gamma-sterilized pre-filter and virus filter combination is pegasus protect virus prefiltration combined with prime virus filtration. Hence, major key players in this region are expected to boost market growth.

Competitive Landscape

The global virus filtration market is moderately competitive with mergers, collaborations, and product launches. Some of the key players in this market are Asahi Kasei Medical Co. Ltd, Charles River Laboratories International Inc., General Electric Company, Pall Corporation, Merck KgaA, Sartorius Group, Pendotech

Asahi Kasei Medical Co. Ltd

Overview: Asahi Kasei Corp. develops fiber products, chemicals, and electronic related materials and globally pursues growth opportunities in areas that can leverage technological advantages. The company was founded in 1974.

Product Portfolio: Planova BioEX is an excellent virus filter choice for biopharmaceutical products due to its superior filtration performance, robust virus removability, and unrivaled quality.

Why Purchase the Report?

Visualize the composition of the global virus filtration market segmentation by product, by application, and end-user highlighting the key commercial assets and players.

Identify commercial opportunities in global virus filtration market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global virus filtration market- level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global virus filtration market report would provide an access to an approx. 45+market data table, 40+figures and 190 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Market Segmentation

Global Virus Filtration Market- By Product

Kits, Reagents, and Consumables

Filtration Systems

Services

Global Virus Filtration Market-By Application

Biological

Vaccines and Therapeutics

Blood and Blood Products

Cellular and Gene Therapy Products

Tissue and Tissue Products

Other

Medical Devices

Water Purification

Air Purification

Other

Global Virus Filtration Market- By End User

Pharmaceutical and Biotechnology Companies

Contract Research Organizations (CROs)

Other

Global Virus Filtration Market- By Region

North America

Europe

South America

Asia Pacific

Middle East and Africa

1. Global Virus Filtration Market Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Global Virus Filtration Market- Market Definition and Overview

3. Global Virus Filtration Market- Executive Summary

3.1. Market Snippet By Product
3.2. Market SnippetBy Application
3.3. Market Snippet By End User
3.4. Market Snippet By Region

4. Global Virus Filtration Market-Market Dynamics

4.1. Market Impacting Factors
- 4.1.1. Drivers:
  - 4.1.1.1. The increasing R&D
- 4.1.2. Restraints:
  - 4.1.2.1. The problems associated with virus filtration
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Global Virus Filtration Market- Industry Analysis

5.1. Porter's Five Forces Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Unmet Needs

6. Global Virus Filtration Market- COVID-19 Analysis

6.1. Analysis of Covid-19 on the Market
- 6.1.1. Before COVID-19 Market Scenario
- 6.1.2. Present COVID-19 Market Scenario
- 6.1.3. After COVID-19 or Future Scenario
6.2. Pricing Dynamics Amid Covid-19
6.3. Demand-Supply Spectrum
6.4. Government Initiatives Related to the Market During Pandemic
6.5. Manufacturers Strategic Initiatives
6.6. Conclusion

7. Global Virus Filtration Market- By Product

7.1. Introduction
7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
7.3. Market Attractiveness Index, By Product
- 7.3.1. Kits, Reagents, and Consumables
  - 7.3.1.1.1. Introduction
  - 7.3.1.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
- 7.2.2. Filtration Systems
- 7.2.3. Services

8. Global Virus Filtration Market-By Application

8.1. Introduction
8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
8.3. Market Attractiveness Index,By Application
- 8.3.2. Biological
  - 8.3.2.1.1. Introduction
  - 8.3.2.1.2. Market Size Analysis, US$ Mn, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
  - 8.3.2.1.3. Vaccines and Therapeutics
  - 8.3.2.1.4. Blood and Blood Products
  - 8.3.2.1.5. Cellular and Gene Therapy Products
  - 8.3.2.1.6. Tissue and Tissue Products
  - 8.3.2.1.7. Other
- 8.3.3. Medical Devices
- 8.3.4. Water Purification
- 8.3.5. Air Purification
- 8.3.6. Other

9. Global Virus Filtration Market- By End User

9.1. Introduction
- 9.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 9.1.3. Market Attractiveness Index, By End User
9.2. Pharmaceutical and Biotechnology Companies*
- 9.2.2. Introduction
- 9.2.3. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029
9.3. Contract Research Organizations (CROs)
9.4. Other

10. Global Virus Filtration Market- By Region

10.1. Introduction
- 10.1.2. Market Size Analysis, US$ Million, 2020-2029 and Y-o-Y Growth Analysis (%), 2021-2029, By Region
- 10.1.3. Market Attractiveness Index, By Region
10.2. North America
- 10.2.2. Introduction
- 10.2.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.2.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
- 10.2.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.2.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.2.6.1. U.S.
  - 10.2.6.2. Canada
  - 10.2.6.3. Mexico
10.3. Europe
- 10.3.2. Introduction
- 10.3.3. Key Region-Specific Dynamics
- 10.3.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.3.5. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
- 10.3.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.3.7. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.3.7.1. Germany
  - 10.3.7.2. U.K.
  - 10.3.7.3. France
  - 10.3.7.4. Italy
  - 10.3.7.5. Spain
  - 10.3.7.6. Rest of Europe
10.4. South America
- 10.4.2. Introduction
- 10.4.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
- 10.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.4.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.4.6.1. Brazil
  - 10.4.6.2. Argentina
  - 10.4.6.3. Rest of South America
10.5. Asia Pacific
- 10.5.2. Introduction
- 10.5.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
- 10.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User
- 10.5.6. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
  - 10.5.6.1. China
  - 10.5.6.2. India
  - 10.5.6.3. Japan
  - 10.5.6.4. Australia
  - 10.5.6.5. Rest of Asia Pacific
10.6. Middle East and Africa
- 10.6.2. Introduction
- 10.6.3. Key Region-Specific Dynamics Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
- 10.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%),By Application
- 10.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By End User

11. Global Virus Filtration Market- Competitive Landscape

11.1. Key Developments and Strategies
11.2. Company Share Analysis
11.3. Product Benchmarking

12. Global Virus Filtration Market- Company Profiles

12.1. Asahi Kasei Medical Co. Ltd*
- 12.1.2. Company Overview
- 12.1.3. Product Portfolio and Description
- 12.1.4. Key Highlights
- 12.1.5. Financial Overview
12.2. Charles River Laboratories International Inc.
12.3. General Electric Company
12.4. Pall Corporation
12.5. Merck KgaA
12.6. Sartorius Group
12.7. Pendotech

LIST NOT EXHAUSTIVE